Search results
Found 10546 matches for
Twigg/Wilkie Group - Building the skull – normal and abnormal development
Using a combination of patient samples and mouse models, we study the causes and developmental origins of skull malformation. The work ranges from screening human DNA for new mutations, to use of genome editing and single cell transcriptomics to model the developmental causes of these malformations in mice. Projects on offer would particularly appeal to students interested in genetics, genomics and developmental mechanisms and for whom clinical application is a key motivator. There will be particular opportunities to learn core bioinformatics skills, perform single cell analysis, and use genome editing to generate and characterise mouse models to understand disease mechanisms.
Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development
Our research group interests lie at the intersection of computational biology and human immunology, in particular in the applications of ‘omics, single cell and spatial technologies for the better understanding of tissue microenvironment, local tissue dynamics and cellular interactions, how they are established during development, and the molecular perturbations and tissue remodelling that occurs in disease states, in particular in autoimmune and autoinflammatory conditions. In order to address these types of questions, our group focuses on inter-disciplinary expertise in both biology and computational biology to both to extract relevant biological insights from complex datasets and to develop domain-tailored machine learning models and novel computational methods for high-dimensional sequencing data analysis.
Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity
An effective T cell response is orchestrated upon T cell recognition of MHC-presented antigens on the surface of infected cells or specialized antigen-presenting cells. A deeper understanding of the rules underpinning T cells recognition of antigens would allow further harnessing of the adaptive T cell immunity and may lead to the development of new personalized vaccines and other immunotherapeutic strategies. The research interests in the Koohy’s group are focused on development of machine-learning and statistical model to help us better understand the grammar of adaptive T cell immunity. Here are a few examples showcasing a few active research projects:
Higgs Group - Laboratory of Gene Regulation
Our laboratory is interested in the general question of how mammalian genes are switched on and off during lineage commitment and differentiation. We use the most recent genomics technologies and computational approaches to study both the entire genome and individual genes in detail. We study all aspects of gene expression including the key cis-regulatory elements (enhancers, promoters and insulators), the transcription factors and co-factors that bind them, the epigenetic modifications of chromatin and DNA, and the role of associated phenomena such as chromosome conformation and nuclear sub-compartmentalisation using state-of-the-art imaging techniques. These studies are performed both in cell systems and in model organisms as well as in material from human patients with various inherited and acquired, genetic and epigenetic abnormalities. The translational goal of our work is to develop new ways to modify gene expression during blood formation with the aim of manipulating gene expression and ameliorating the clinical phenotypes of patients with a variety of blood disorders.
Mead Group - Haematopoietic Stem Cell Biology
The overarching focus of my research group is to characterise genetic and cellular heterogeneity in myeloproliferative neoplasms (MPN) with the ultimate goal to improve the diagnosis, risk-stratification and treatment of these largely incurable forms of blood cancer.
Nerlov Group - Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing
The Nerlov laboratory studies the fundamental processes by which blood stem cells sustain blood cell production throughout life, and how ageing and haematological malignancies perturb this process.
Psaila Group - Megakaryocytes, platelets and Malignant Bone Marrow Fibrosis
Megakaryocytes, platelets and Malignant Bone Marrow Fibrosis
Davies Group - Genomics and Genome Editing
James Davies
Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints
Our focus has been on the cell biology of the T-cell surface. We developed general methods for crystallizing glycoproteins and determined the structures of key T-cell surface proteins including the first adhesion protein (CD2) and its ligand CD58, the costimulatory receptor CD28 and its ligand CD80, the large tyrosine phosphatase CD45, and most recently a ligand-bound T-cell receptor (TCR). We also worked out how weak, specific recognition is achieved by these types of proteins and obtained the first insights into the overall composition of the T-cell surface. Most importantly we proposed, with PA van der Merwe, one of the most complete and best-supported explanations for leukocyte receptor triggering, called the kinetic-segregation model (youtube.com/watch?v=HygSTSlycok).
Goriely Group - Clinical Genetics
De novo mutations (DNMs) are a significant contributor to human disease, affecting ~1:300 new births. We study the mechanisms by which these spontaneous mutations arise in the first instance, concentrating on the tissue where most originate, the human testis. We aim to understand why some pathogenic mutations arise more frequently than others and how the mechanisms regulating the production of sperm influences this process.
Drakesmith Group - Iron and Immunity
We study how iron and anaemia influence immunity and infectious diseases. Our research inspires therapies that control iron physiology to improve immunity, combat infections and treat disorders of iron metabolism. We work across the disciplines of immunology, haematology and global health, utilising in vitro, in vivo and human studies, and collaborate extensively to translate our mechanistic discoveries into clinically relevant progress.